A record of what Manishi Raychaudhuri said publicly, with the source. Not advice.
I
Manishi Raychaudhuri
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
1 awaiting resolution
Scored on trackable calls only. Long-horizon and commentary opinions are listed below but not counted in this score.
Recent calls
Newest first. Every call links back to its original source.
| Call | Instrument | Verdict | Actions |
|---|---|---|---|
| “IT stocks may only become attractive at valuations closer to 10-12 times earnings, implying either downside or a prolong…” | Infosys | — | |
| “Manishi Raychaudhuri suggests that a sustained return of foreign institutional buying in India may be difficult until th…” | Nifty 50 | — | |
| “Manishi Raychaudhuri flags consumer staples and IT services as areas of caution. Consumer staples suffer from low growth…” | Nifty IT | — | |
| “Indian equities are unlikely to see a visible earnings revival in the near term, as hard evidence for acceleration remai…” | Nifty 50 | — | |
| “The Indian IT sector faces a challenging near-term outlook, being pulled in opposite directions by AI. While AI data cen…” | Nifty IT | — | |
| “Manishi Raychaudhuri pegs a Sensex target of 91,000 by the end of 2026, implying a 7-8% upside. He maintains an 'overwei…” | Sensex | PENDING | |
| “Bullish on frontline largecap banks, despite concerns about potential deterioration in retail and microfinance asset qua…” | Nifty Bank | — | |
| “Bullish on private sector banks, noting their strong performance, technological capabilities, and a long-term trend of g…” | Nifty Private Bank | — | |
| “Continues to prefer private sector banks, citing their market share gains, superior technological platforms, and better …” | Nifty Private Bank | — | |
| “Indian markets are expected to take a near-term breather or undergo a time correction after a solid 10-15% run since Apr…” | Nifty 50 | — | |
| “Bullish on the Pharmaceutical sector, as almost 50% of US imported generics come from India, and the sector has been lar…” | Nifty Pharma | — | |
| “Bearish on the IT sector in the short term due to concerns about demand retrenchment in the United States, which will le…” | Nifty IT | — | |
| “In the near term, investors should not invest in India, not even in ETFs, due to high valuations. India's forward PE tra…” | Nifty 50 | — |
By instrument
Graded calls broken down by what was being called.
Sensex
1 pending